Transamerica Life Insurance Fit Review for Bipolar Disorder

Research Snapshot

Why Transamerica Qualified for This Study

Questions This Section Answers

• Is Transamerica a good choice for life insurance if I have bipolar disorder?
• Why did AI platforms include Transamerica in a bipolar disorder life insurance ranking?

Transamerica qualified because it was named by four of the seven platforms during ranking discovery, and because it is one of the few carriers in this study with a published underwriting framework that explicitly addresses mood disorders. Transamerica's own brokerage underwriting primer groups psychiatric risk under anxiety and mood disorders and states that eligibility and pricing depend on severity, treatment response, time lost from work, hospitalization, suicide history, substance use, and comorbidities ^[1]. A separate Transamerica mental health questionnaire asks directly about bipolar diagnosis, treatment, and hospitalizations ^[2], and a Transamerica final expense application includes a direct bipolar disorder question ^[3].

That documented screening is why the entity surfaced at all. It is also why the fit is contested: the same documents that make Transamerica relevant also show that bipolar disorder is a rated or declined condition at the severe end. One platform's underwriting guide summary maps mild bipolar disorder to Table 2 through Table 4 ratings, moderate to Table 4 through Table 6, and severe to Table 8 through decline ^[4].

Transamerica's ranking position was mid-pack. Its average listed rank of 7.5 across the four naming platforms reflects that it was included as a viable option rather than recommended as a first choice. This review covers Transamerica only for the bipolar disorder use case; it is not a general company assessment.

The Product, Model, Plan, or Service Most Relevant to Life Insurance for Bipolar Disorder

Questions This Section Answers

• Which Transamerica plan should a buyer with bipolar disorder choose if they need coverage without a medical exam?
• Is Transamerica Trendsetter LB or Transamerica final expense better for someone with a bipolar diagnosis?

Two Transamerica product families matter for this use case, and they serve different buyers.

Transamerica Final Expense Solutions Portfolio is the more accessible path. It is simplified-issue whole life with coverage generally described between $5,000 and $100,000 depending on product and age, no medical exam, and either guaranteed or graded death benefits depending on risk tier ^[5]. The portfolio includes Immediate Solution, 10-Pay Solution, and Easy Solution ^[7]. One platform reports FE Express Solutions decisions in as little as 10 minutes through an all-digital application ^[8].

Transamerica Trendsetter LB is the larger-coverage path. It offers 10-, 15-, 20-, 25-, or 30-year level-premium periods, face amounts from $25,000 to $2 million, and multiple underwriting risk classes ^[9]. It includes accelerated-benefit features for qualifying terminal, chronic, and critical illnesses, subject to policy terms and state availability ^[9]. Non-medical underwriting may be available up to $249,999 in some risk classes ^[11], and Transamerica states its term underwriting offers no medical exam up to $2 million for qualified applicants ^[12].

The critical distinction: neither product is guaranteed issue in the individual retail portfolio. Transamerica's own press release states FE Express is not guaranteed issue and remains subject to underwriting ^[13]. One platform states plainly that Transamerica does not offer individual guaranteed-issue retail policies and that Easy Solution still requires answering simplified health questions ^[15]. Third-party sources conflict on this point — one describes Immediate Solution as guaranteed issue ^[16] — so buyers should treat the issue type as product- and state-specific and confirm it in writing.

What the AI Platforms Agreed About

Questions This Section Answers

• Do AI platforms agree that Transamerica accepts bipolar disorder applicants for final expense coverage?
• What do reviewers agree Transamerica requires before it will issue a policy to someone with bipolar disorder?

Three findings drew broad agreement across the seven platform responses.

First, Transamerica screens bipolar disorder explicitly rather than ignoring it. A Transamerica mental health questionnaire asks about bipolar diagnosis, treatment, and hospitalizations ^[17], and a final expense application contains a direct bipolar question ^[18]. Transamerica's underwriting primer identifies hospitalization within the prior 12 months, recent suicide attempt or thoughts, and multiple suicide attempts as stated coverage knockouts for the referenced anxiety/mood-disorder category ^[19].

Second, skipping the medical exam does not skip underwriting. Multiple platforms state that non-medical and simplified-issue applications still involve MIB checks, prescription database checks, medical history review, and possible attending-physician statements, paramedical exams, blood, and urine tests ^[20].

Third, the final expense tier is the more realistic path for applicants who cannot pass full underwriting. Platforms consistently describe final expense as the product line where a bipolar applicant with a controlled condition has the best chance of an immediate-benefit offer, with graded benefits reserved for higher-risk cases ^[24].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• Is Transamerica's final expense product guaranteed issue or simplified issue for a bipolar applicant?
• How much more will a buyer with bipolar disorder pay at Transamerica than a standard-rate applicant?

Platform verdicts split. Two platforms rated Transamerica a "good" fit (anthropic, google), four rated it "mixed" (openai, deepseek, grok, perplexity), and one rated it "uncertain" (kimi). That spread is the single clearest signal in this study: there is no consensus that Transamerica is a strong bipolar-specific choice.

Four specific conflicts matter to a buyer.

Guaranteed issue versus simplified issue. Transamerica's own press release says FE Express is not guaranteed issue ^[27], while a third-party 2026 review describes Immediate Solution as guaranteed issue ^[29]. One platform concluded that Transamerica offers no true individual guaranteed-issue retail policy ^[30]. This is unresolved in the public record.

Whether Transamerica is bipolar-friendly at all. One platform found that independent sources describing bipolar-friendly carriers do not name Transamerica, and rated the fit "uncertain" on that basis ^[31]. Another found that Transamerica's build chart is among the most generous and that it underwrites anxiety and depression more reasonably than many competitors ^[33]. Both are platform-reported characterizations, not verified underwriting rules.

Pricing. No platform produced a bipolar-specific Transamerica premium. One platform cites industry patterns of 50–300% premium increases for mental health conditions if approved, with table ratings the most common outcome ^[34]. Another cites a final expense example of $61 per month for $10,000 at age 65 Select non-smoker, versus $41 per month from a competitor for the same profile ^[35]. Neither figure is a bipolar-adjusted quote.

Service quality. One platform reports a NAIC complaint index of 3.86 against an industry average of 1.0, a J.D. Power score of 604 ranking 18th of 21 carriers, and a BBB rating of 1.66 out of 5 stars ^[36]. Another reports a J.D. Power rank of 22 out of 23 ^[37]. These are independent review metrics, not company statements, and they conflict with Transamerica's own marketing emphasis on service.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• What underwriting factors does Transamerica use to rate a bipolar disorder applicant?
• Does Transamerica offer a graded death benefit for someone disabled by bipolar disorder?

Transamerica's underwriting for this condition turns on severity, stability, and functional impact. The published framework distinguishes mild, moderate, and severe presentations. Mild cases — no work loss, low-dose single medication — are described as Table 2 to Table 4; moderate cases with one or more episodes and satisfactory treatment as Table 4 to Table 6; severe cases with recurring episodes, inpatient care, or work disability as Table 8 to decline ^[38]. An attending physician statement is described as highly likely to be required for traditional underwriting of bipolar disorder ^[39].

On the final expense side, the reported tiers are more granular. Bipolar disorder can qualify for Preferred rates where there are no symptoms or work loss in the past six months and the condition is controlled with zero to one medications, and for Standard rates where there is no inpatient care, no more than two episodes or two weeks of work or school loss in the past 12 months, and control on one to two medications ^[40].

For applicants disabled by bipolar disorder but stable on medication for at least two years, the Easy Solution graded death benefit product is described as an available path ^[40]. Graded policies limit the payout in the first two years for non-accidental causes; one platform reports the graded benefit returns premiums plus 10% if death occurs in the first two years from a non-accident ^[41]. A standard two-year suicide and contestability clause applies ^[40].

Living benefits on Trendsetter LB cover qualifying terminal, chronic, and critical illness. These are not bipolar-disorder benefits and should not be treated as mental-health coverage ^[42].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does Transamerica cost per month for final expense coverage, and are there policy fees?
• What happens to Transamerica Trendsetter LB premiums after the initial level term period ends?

No platform produced a bipolar-adjusted Transamerica quote, and pricing confidence was rated low by four of the seven platforms. The figures below are product-level reference points, not offers.

Contract terms that matter: Trendsetter LB premiums increase after the initial level period under the cited policy form ^[44]. Term conversion may be available without new underwriting for qualifying conversions, subject to policy and jurisdiction rules ^[44]. Living-benefit acceleration reduces the remaining death benefit ^[44]. Whole life policies require premiums to remain current for stated guarantees to continue ^[45]. Free-look periods typically run 10 to 30 days depending on state ^[46].

Exact free-look, lapse, reinstatement, surrender, conversion, and cancellation terms were not verified for any specific buyer's state or product version ^[44]. Optional riders carry additional cost ^[44].

Best Suited For

Questions This Section Answers

• Who is Transamerica actually a good fit for among buyers with bipolar disorder?

Transamerica is best suited to applicants with stable, consistently treated bipolar disorder who can complete underwriting and who want either a modest permanent policy or a term policy with a meaningful face amount.

The specific profiles platforms identified: applicants with stable bipolar disorder who can complete full medical underwriting (openai); stable bipolar II cases with two or more years of consistent medication and no recent hospitalizations (anthropic); applicants seeking final expense coverage in the $5,000–$100,000 range with simplified underwriting and no medical exam (anthropic, deepseek); applicants needing term coverage up to $2 million without a medical exam (anthropic); individuals disabled by bipolar disorder who have been stable on medication for at least two years and are comfortable with a graded death benefit (google); and buyers prioritizing lower premiums over premium customer service (anthropic).

A recurring theme across platforms is that this profile should be submitted through a broker who specializes in mental-health underwriting. One platform notes that each declined application is reported to the Medical Information Bureau and that multiple declines damage future approval odds, which is why pre-screening matters ^[49].

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose Transamerica for life insurance with bipolar disorder?

Transamerica is a weak fit for applicants whose psychiatric history includes recent instability or who need certainty of acceptance before disclosing medical history.

Platforms consistently flagged these profiles as poor matches: applicants with recent psychiatric hospitalization, recent suicidal ideation or attempts, significant functional impairment, or recent substance-abuse history (openai); applicants with recent bipolar diagnoses with less than two years of stability (anthropic); applicants with severe, unstable bipolar disorder, recent hospitalizations, or a history of self-harm within the past three years (google); applicants needing a true individual guaranteed-issue policy with zero medical questions (google); applicants needing large permanent coverage rather than term or final-expense protection (openai); and buyers who expect responsive, premium customer service during claims (anthropic).

One platform went further and rated the overall fit "uncertain," noting that no independent source ranks Transamerica among bipolar-friendly carriers and that its specific underwriting criteria for the condition are proprietary and undisclosed ^[51]. That is a platform-reported judgment, not a verified finding, but it is a fair statement of the evidence gap.

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to Transamerica for a buyer with bipolar disorder who needs large term coverage?
• When should a buyer with bipolar disorder skip Transamerica and use a guaranteed-issue carrier instead?

Another carrier may be better in five situations platforms identified.

When the applicant needs coverage above final-expense limits and cannot qualify for medically underwritten term. Final expense face amounts top out well below income-replacement needs, and term coverage requires underwriting that a severe presentation may not pass (openai, deepseek).

When the applicant has recent psychiatric instability. A carrier or product specifically designed for impaired-risk or guaranteed-issue coverage is the more realistic path (openai, perplexity).

When the applicant is in New York. Trendsetter Super is reported unavailable in New York, and some indexed universal life products are restricted in California and New York ^[53].

When speed matters more than price. Fully underwritten Transamerica cases are reported to run four to seven weeks, slower than digitally native carriers ^[55].

When the applicant prioritizes permanent cash-value coverage or dividend-paying whole life. Transamerica's whole life final expense product is non-participating, and platforms noted that mutual carriers offer superior policy design for long-term accumulation (anthropic).

One platform also noted that group life insurance through employment skips individual mental-health underwriting entirely, which can be a faster path to coverage than any individual application ^[56].

Questions to Verify Before Buying

Questions This Section Answers

• What should a buyer confirm with Transamerica before signing a bipolar disorder life insurance application?

These questions come directly from the platform research and should be resolved before any formal application is submitted.

1. Is the specific product simplified issue or guaranteed issue in the applicant's state, and under the current 2026 policy form? (openai, perplexity)
2. Does Transamerica classify the diagnosis as bipolar I, bipolar II, cyclothymia, or another mood-disorder category for underwriting purposes? (openai)
3. What recent episode-free period, medication stability period, and work-function criteria apply to this application? (perplexity, google)
4. What are the current rules for hospitalization, suicidal ideation or attempts, self-harm, substance use, disability, and emergency treatment? (openai)
5. Will an attending-physician statement, medical exam, labs, prescription report, or psychiatric records be required? (openai, anthropic)
6. What table rating, exclusion, postponement, or decline scenario should the applicant expect based on diagnosis type, medication history, and years stable? (anthropic, google)
7. What is the exact premium schedule after the initial term-level period, and what happens if premiums are missed? (openai)
8. For final expense coverage, is the death benefit immediate or graded, and what are the contestability and suicide-period provisions? (openai, anthropic)
9. Can the broker obtain an informal or preliminary underwriting assessment without creating a formal decline on record? (kimi, anthropic)
10. What are the conversion, cancellation, surrender, reinstatement, free-look, and rider-cost terms in the applicant's state? (openai, perplexity)

Final AI Consensus Verdict

Transamerica is a mixed fit for life insurance with bipolar disorder, and the platform split reflects genuine uncertainty rather than a settled answer. Two platforms rated it "good," four "mixed," and one "uncertain." It was named by four of seven platforms during ranking, with an average listed rank of 7.5 and a best rank of 3.

The case for Transamerica rests on product structure: a simplified-issue final expense portfolio with no medical exam, a term product with no-exam capacity up to $2 million for qualified applicants, and a published underwriting framework that at least acknowledges mood disorders and assigns severity-based ratings. The case against rests on the absence of any bipolar-specific consumer eligibility guide, a documented set of knockouts around recent hospitalization and self-harm history, unresolved conflicts about whether any Transamerica product is truly guaranteed issue, and independent service metrics that are well below industry averages.

The practical conclusion supported by this evidence: Transamerica is worth including in a broker-assisted comparison for a stable, consistently treated applicant, particularly for final expense coverage or a modest term policy. It should not be treated as a guaranteed-acceptance solution, and it should not be the only carrier quoted. Buyers who want to see how Transamerica compares against the other carriers evaluated for this condition can review the full Life Insurance for Bipolar Disorder consensus index, and general coverage context is available in the life insurance category directory.

How This Review Was Produced

This review was produced from a structured multi-platform research run dated 2026-09-22. Seven AI platforms evaluated Transamerica for the specific use case of life insurance for a consumer diagnosed with bipolar disorder: anthropic (claude-haiku-4-5-20251001), deepseek (deepseek-v4-flash), google (gemini-3.5-flash), grok (x-ai/grok-4.3), kimi (moonshotai/kimi-k2.6), openai (gpt-5.6-luna), and perplexity (perplexity/sonar). Six of the seven had search enabled; deepseek ran without search.

Each platform returned a fit rating, a direct answer, strengths and limitations for the use case, pricing and contract observations, factual conflicts, and questions to verify before buying. Transamerica was named during the ranking stage by four of the seven platforms. All seven platforms evaluated fit, but only the four that named the entity during ranking discovery count toward the platform mention total.

Citations in this article are platform-reported evidence. They were not independently verified by the writer stage, and the supplied URLs were collected from platform responses rather than validated separately.

Methodology Limitations

Several limitations apply to every finding in this review.

No verified bipolar-specific underwriting outcome exists. No platform produced a Transamerica underwriting manual section, approval rate, or rate table specific to bipolar disorder. All severity-tier and table-rating descriptions are platform-reported summaries of company or distributor documents, not confirmed current rules.

Research dates differ. The authoritative run date is 2026-09-22, and six platforms reported that date. Deepseek reported 2026-01-15. Platform-reported dates are provenance metadata and do not independently prove freshness.

Source material is partly dated. The psychiatric underwriting primer is older than the research date and expressly states that guidelines may change without notice ^[57]. The final expense public page is associated with older material and includes historical COVID-era application language, so current availability and limits are unclear ^[58]. Several distributor-hosted underwriting guides date to 2014 or 2015 ^[59].

Product availability varies. Policy forms, riders, underwriting limits, and New York or other state restrictions may differ by state and issue date ^[61].

Pricing is unverified. No platform produced a bipolar-adjusted premium. All dollar figures are product-level reference points from company guides or independent reviews, and pricing confidence was rated low by four platforms.

Service metrics conflict with company positioning. Independent complaint and satisfaction indices are well below industry averages, while company and broker materials emphasize service improvements. This review reports both and resolves neither.

Platform agreement is not evidence of quality. That multiple platforms named Transamerica does not establish that it is a good carrier for this condition. It establishes that the platforms considered it relevant enough to rank.

No personal testing or customer experience is reported here. Nothing in this review reflects direct product testing, claims experience, or independent verification of Transamerica's underwriting behavior.